ARCHIVES

ODAC’s Dilemma: Proposed Indication Created By Reliance On PSA Screening and Hormonal Treatment

This article is from The Cancer Letter archive.

Vol. 37 No. 35 | September 23, 2011

Download PDF Visit The Full Archive

Related Articles

Two Trials Presented at ASCO Demonstrate Drop in Death Risk, Increased Survival

June 24, 2011

Final Issue of 1980

December 19, 1980

Van Nevel New NCI information Chief: Karel Leaves For Johnson Foundation

August 30, 1974

FOLFOX 4 Should Be First-Line Therapy For Advanced Disease, NCCTG Finds

December 26, 2003

Toxic Wastes And Cancer Linked; NCI Data Questioned In Bay Study

December 13, 1985

October issue of Business & Regulatory Report (8-page issue).

November 2, 2002